MedinCell S.A.
$25.02▼ 5.08%($-1.34)
TickerSpark Score
34/100
▌ Poor
47
Valuation
20
Profitability
10
Growth
64
Health
30
Momentum
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MEDCL.PA research report →
52-Week Range40% of range
Low
$15.39
Current
$25.02
High
$39.68
Company Overviewwww.medincell.com
About the company
MedinCell S. A. specializes in pioneering diverse therapeutic treatments.
- CEO
- Christophe Douat
- IPO
- 2018
- Employees
- 131
- HQ
- Jacou, FR
Price Chart
+49.46% · this period
Valuation
- Market Cap
- $898.39M
- P/E
- -27.49
- P/S
- 46.03
- P/B
- -29.33
- EV/EBITDA
- -30.09
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- -130.65%
- Net Margin
- -160.30%
- ROE
- 133.14%
- ROIC
- -37.53%
Growth & Income
- Revenue
- $19.52M · -23.58%
- Net Income
- $-31,287,000 · -69.69%
- EPS
- $-0.87 · -38.10%
- Op Income
- $-25,502,000
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $39.68
- 52W Low
- $15.39
- 50D MA
- $26.08
- 200D MA
- $26.16
- Beta
- 1.02
- Avg Volume
- 112.77K
Get TickerSpark's AI analysis on MEDCL.PA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Coverage · MEDCL.PA
Our MEDCL.PA coverage
Recent articles, reports, and earnings notes.
On-Demand Research
No research on MEDCL.PA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MEDCL.PA report →Internal Compare
Similar companies
Peers in the same neighborhood.